- Public Health - Prescription Drug Monitoring Program - Revisions
- Sponsored by
- Delegates Barron, Hettleman, Korman, Moon, Pendergrass, Pena-Melnyk, Bagnall, Bhandari, Carr, Charles, Chisholm, Cullison, Hill, Johnson, Kelly, Kerr, Kipke, Krebs, R. Lewis, Metzgar, Morgan, Rosenberg, Saab, Sample-Hughes, Szeliga, and K. Young
- Approved by the Governor - Chapter 531
- Fiscal and Policy Note
Requiring, instead of authorizing, the Prescription Drug Monitoring Program to review prescription monitoring data for indications of a possible misuse or abuse of a monitored prescription drug; requiring the Program to report the possible misuse or abuse to the prescriber or dispenser of the monitored prescription drug and to provide certain education to the prescriber or dispenser; authorizing the Program to provide prescription monitoring data to the Office of Controlled Substances Administration for further investigation; etc.
( 21-2A-01, 21-2A-02, 21-2A-04, 21-2A-05, 21-2A-06, 21-2A-07 )
Last Updated: 2/3/2020 2:29 PM